Combination SGLT2 Inhibitor and Glucagon Receptor Antagonist Therapy in Type 1 Diabetes: A Randomized Clinical Trial
Diabetes Care. 2024 May 22:dc240212. doi: 10.2337/dc24-0212. Online ahead of print. ABSTRACT OBJECTIVE: To examine the effects of insulin-adjunctive therapy with a sodium-glucose cotransporter 2 …